Quantcast
Connect with us

Heather Bresch dumped more than 100,000 shares of Mylan — just two weeks before EpiPen scandal

Published

on

The embattled CEO of Mylan dumped more than 10 percent of her shares of the pharmaceutical company’s stock as analysts warned she could become the next “Pharma bro.”

Heather Bresch sold off 100,200 shares of Mylan stock on Aug. 9, the same day the drugmaker released its most recent earnings report amid questions over the swiftly ballooning cost of EpiPens, reported The Guardian.

ADVERTISEMENT

Wells Fargo analyst David Maris issued a report in early June pointing out that Mylan had jacked up the prices of seven products by 100 percent more, while raising the cost of another 24 products by at least 20 percent.

Maris warned that Bresch and her company could face a similar public relations nightmare as Martin Shkreli, who became widely loathed after raising the cost of the anti-nausea drug Daraprim by more than 5,000 percent.

Shkreli was arrested in December on security fraud charges related to a hedge fund he co-founded, and he later resigned as CEO of Turing Pharmaceuticals.

Bresch had other warnings that she and her company were about to become similarly toxic.

ADVERTISEMENT

Other media outlets — including CNBC, Bloomberg and FiercePharma — published reports questioning Mylan’s price hikes, and Bloomberg reported in September 2015 how Bresch had turned EpiPen into a marketing success and raised its price 400 percent.

EpiPen jumped in price by 15 percent twice more since then, and Slate last month questioned the life-saving allergy drugs cost in a story titled: “There’s absolutely no reason why an EpiPen should cost $300.”

Bresch dumped hundreds of thousands of Mylan shares one month and one day after Slate’s report.

ADVERTISEMENT

A company spokeswoman said the Aug. 9 transaction was made as part of a 10b5 plan, which executives at publicly traded companies use to establish a waiting period to avoid suspicion of trading based on non-public information.

“Simply put, 10b5 plans are used to avoid being suspected of insider trading,” wrote The Guardian‘s Jana Kasperkevic.

Mylan’s stock price dropped from $49 on Aug. 18 to $42.91 on Aug. 26, after the EpiPen controversy erupted.

ADVERTISEMENT

Bresch, who has seen her own pay shoot up by 671 percent over the past nine years, currently holds 828,318 shares of Mylan.


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

The week Donald Trump’s presidency crashed and burned — and Republicans noticed

Published

on

It feels as though every week during the Trump administration is a year and every year a decade. Every day there is a crisis or an outrage or a revelation that takes your breath away. But the underlying dynamics always seem to be the same no matter what. The press reports the story, the Democrats get outraged, the pundits analyze it, the president rages and then Fox and the Republicans all line up like a bunch of robots and salute smartly. Then we reset until the next crisis, outrage or revelation. It's an exhausting cycle that never seems to get us anywhere and it's bred a fatalistic response in many of us: "Nothing matters."

Continue Reading

Breaking Banner

Turkish president threatens US over Trump’s insulting letter: ‘When the time comes necessary steps will be taken’

Published

on

Turkish President Recep Tayyip Erdo?an on Friday warned the United States that it would pay a price for the letter send by President Donald Trump that warned him that history "will look upon you forever as the devil if good things don't happen" in northern Syria.

The letter, which also advised Erdo?an to not "be a tough guy" or "a fool," was widely ridiculed in the media for sounding childish. Erdo?an, however, said on Friday that he took the president's letter as a serious insult to his stature as a world leader.

As reported by the BBC's Jon Sopel, Erdo?an called out the president's letter for being out of line with standard diplomatic protocol, and he suggested his country would not forget how the president showed them such little respect.

Continue Reading
 

Breaking Banner

‘We’re ready to vote’: Oversight Committee Dem claims Congress has the goods for impeachment

Published

on

Appearing on CNN's "New Day," Democratic Rep. Ro Khanna (CA), who sits on the House Oversight Committee, said he and other Democrats have enough in hand to vote on the impeachment of President Donald Trump.

Speaking with host John Berman, Khanna was pressed on what he had learned behind closed doors from former and current officials working in Trump's administration, saying he couldn't divulge any more than has previously been released but that there was enough there to raise serious issues about Trump's continuing as president.

Pressed by host Berman whether lawmakers have enough to proceed with impeachment, the California Democrat didn't skip a beat and said yes.

Continue Reading
 
 
Help Raw Story Uncover Injustice. Join Raw Story Investigates for $1 and go ad-free.
close-image